Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing the package: Cell-specific gene delivery using lentiviral vectors.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies.

Molecular therapy. Oncology·2026
Same author

Septin7 is essential in early hematopoiesis, but redundant at later stages.

Life science alliance·2026
Same author

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Human gene therapy·2026
Same author

Capsid-engineered AAV vector overcomes a key intracellular barrier and efficiently transduces spiral ganglion neurons in adult mice.

Molecular therapy. Advances·2026
Same author

Editorial: Community Series in Engineered Immune Cells in Cancer Immunotherapy (EICCI), volume II.

Frontiers in immunology·2026

Related Experiment Video

Updated: Jul 30, 2025

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion
09:18

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion

Published on: April 4, 2025

684

Tumor Organoid and Spheroid Models for Cervical Cancer.

Ivana Kutle1, Robert Polten1, Jens Hachenberg1,2

  • 1Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany.

Cancers
|May 13, 2023
PubMed
Summary

This review explores 3D tumor models like spheroids and patient-derived organoids for developing novel immunotherapies against cervical cancer, aiming to improve treatment outcomes.

Keywords:
3D tumor modelscervical cancerimmunotherapypatient-derived organoids (PDOs)pre-clinical drug teststumor microenvironment (TME)tumor spheroids

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.3K
Mammary Epithelial and Endothelial Cell Spheroids as a Potential Functional In vitro Model for Breast Cancer Research
08:30

Mammary Epithelial and Endothelial Cell Spheroids as a Potential Functional In vitro Model for Breast Cancer Research

Published on: July 12, 2021

4.7K

Related Experiment Videos

Last Updated: Jul 30, 2025

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion
09:18

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion

Published on: April 4, 2025

684
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.3K
Mammary Epithelial and Endothelial Cell Spheroids as a Potential Functional In vitro Model for Breast Cancer Research
08:30

Mammary Epithelial and Endothelial Cell Spheroids as a Potential Functional In vitro Model for Breast Cancer Research

Published on: July 12, 2021

4.7K

Area of Science:

  • Oncology
  • Cancer Research
  • Immunotherapy

Background:

  • Cervical cancer remains a significant global health issue, particularly in low-resource settings.
  • Despite HPV vaccination, high incidence and mortality persist, especially in advanced stages.
  • Novel therapeutic strategies, including immunotherapy, show promise but require rigorous pre-clinical evaluation.

Purpose of the Study:

  • To review the application of 3D tumor models in cervical cancer research.
  • To highlight the potential of spheroids and patient-derived organoids (PDOs) for pre-clinical therapy testing.
  • To focus on immunotherapies targeting cancer cells and the tumor microenvironment (TME).

Main Methods:

  • Review of current literature on 3D tumor models in cervical cancer.
  • Analysis of spheroid and PDO applications in pre-clinical immunotherapy research.
  • Emphasis on models that mimic tumor architecture and microenvironment.

Main Results:

  • 3D tumor models offer a more accurate representation of in vivo tumor biology than 2D cultures.
  • Spheroids and PDOs facilitate the evaluation of novel anti-cancer agents, including immunotherapies.
  • These models aid in understanding treatment response and resistance mechanisms.

Conclusions:

  • 3D tumor models are crucial for advancing cervical cancer therapy development.
  • Spheroids and PDOs represent valuable tools for testing immunotherapies against cervical cancer.
  • Improved pre-clinical models are essential for translating promising therapies into clinical success.